{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:53:35Z","timestamp":1794020015166,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.survophthal.2008.04.005","type":"journal-article","created":{"date-parts":[[2008,6,21]],"date-time":"2008-06-21T04:14:57Z","timestamp":1214021697000},"page":"416-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Ocular Features of Fabry Disease: Diagnosis of a Treatable Life-threatening Disorder"],"prefix":"10.1016","volume":"53","author":[{"given":"Nasi","family":"Samiy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2008.04.005_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1755-3768.1994.tb07193.x","article-title":"Central retinal artery occlusion in a patient with Fabry's disease documented by scanning laser ophthalmoscopy","volume":"72","author":"Andersen","year":"1994","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.survophthal.2008.04.005_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2008.04.005_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2005.04.009","article-title":"Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy","volume":"85","author":"Banikazemi","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.survophthal.2008.04.005_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course","volume":"81","author":"Branton","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.survophthal.2008.04.005_bib5","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.ki.5000208","article-title":"Clinical benefit of enzyme replacement therapy in Fabry disease","volume":"69","author":"Breunig","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.survophthal.2008.04.005_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00003226-199709000-00019","article-title":"Vortex keratopathy in a patient with multiple myeloma","volume":"16","author":"Chong","year":"1997","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2008.04.005_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00006982-200102000-00024","article-title":"Retinal and choroidal vascular changes in heterozygous Fabry disease","volume":"21","author":"Dantas","year":"2001","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2008.04.005_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ndt\/18.1.33","article-title":"Gr\u00fcnfeld JP: Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function","volume":"18","author":"De Schoenmakere","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.survophthal.2008.04.005_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.survophthal.2008.04.005_bib10","series-title":"Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"Alpha-galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.survophthal.2008.04.005_bib11","first-page":"7","article-title":"[Fetal pathology in Fabry's disease and mucopolysaccharidosis type I]","volume":"34","author":"Elleder","year":"1998","journal-title":"Cesk Patol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.survophthal.2008.04.005_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.survophthal.2008.04.005_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2014replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2008.04.005_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-9394(72)90071-2","article-title":"Ocular pathology in fabry's disease. Histochemical and electron microscopic observations","volume":"73","author":"Font","year":"1972","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib16","first-page":"195","article-title":"Fabry disease: ocular manifestations","volume":"12","author":"Franceschetti","year":"1976","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.survophthal.2008.04.005_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1445-5994.2002.00291.x","article-title":"Clinical features of Fabry's disease in Australian patients","volume":"32","author":"Galanos","year":"2002","journal-title":"Intern Med J"},{"key":"10.1016\/j.survophthal.2008.04.005_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/B:BOLI.0000028726.11177.8b","article-title":"Clinical benefit in Fabry patients given enzyme replacement therapy\u2014a case series","volume":"27","author":"Guffon","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.survophthal.2008.04.005_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000076846","article-title":"Results of an ophthalmologic screening programme for identification of cases with Anderson-Fabry disease","volume":"218","author":"Hauser","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2008.04.005_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00003226-200103000-00028","article-title":"Histopathologic findings of cornea verticillata in a woman heterozygous for Fabry's disease","volume":"20","author":"Hirano","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2008.04.005_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.icu.0000143688.45232.15","article-title":"Drug-induced corneal complications","volume":"15","author":"Hollander","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib22","article-title":"Images in clinical medicine","author":"Kopp","year":"2003","journal-title":"Fabry's disease. N Engl J Med 349:e20"},{"key":"10.1016\/j.survophthal.2008.04.005_bib23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.survophthal.2008.04.005_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.survophthal.2008.04.005_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/13816818509006132","article-title":"McCulloch C: Corneal changes in Fabry's disease: a clinico-pathologic case report of a heterozygote","volume":"5","author":"Macrae","year":"1985","journal-title":"Ophthalmic Paediatr Genet"},{"key":"10.1016\/j.survophthal.2008.04.005_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.survophthal.2008.04.005_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2377-2-4","article-title":"Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease","volume":"2","author":"Moore","year":"2002","journal-title":"BMC Neurol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/hs0202.102601","article-title":"Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement","volume":"33","author":"Moore","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.survophthal.2008.04.005_bib29","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.survophthal.2008.04.005_bib30","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/bmj.297.6653.872","article-title":"Anderson-Fabry disease","volume":"297","author":"Morgan","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.survophthal.2008.04.005_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1442-9071.2005.00990.x","article-title":"Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre","volume":"33","author":"Nguyen","year":"2005","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1076\/opge.24.3.129.15609","article-title":"Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients","volume":"24","author":"Orssaud","year":"2003","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.survophthal.2008.04.005_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/112067219800800412","article-title":"Retinal vein occlusion in a woman with heterozygous Fabry's disease","volume":"8","author":"Oto","year":"1998","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.gim.0000200950.25118.dd","article-title":"Quantitative dysmorphology assessment in Fabry disease","volume":"8","author":"Ries","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.survophthal.2008.04.005_bib35","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.survophthal.2008.04.005_bib36","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2008.04.005_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.10497","article-title":"Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease","volume":"28","author":"Schiffmann","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.survophthal.2008.04.005_bib38","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.survophthal.2008.04.005_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archopht.1979.01020010327008","article-title":"The ocular manifestations in Fabry's disease","volume":"97","author":"Sher","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archopht.1978.03910050421003","article-title":"Central retinal artery occlusion complicating Fabry's disease","volume":"96","author":"Sher","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjo.2006.100602","article-title":"Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey","volume":"91","author":"Sodi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib42","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archopht.1965.00970040762005","article-title":"Fabrys disease. Its ocular manifestations","volume":"74","author":"Spaeth","year":"1965","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2008.04.005_bib43","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1755-3768.1984.tb08444.x","article-title":"Corneal findings in a foetus with Fabry's disease","volume":"62","author":"Tsutsumi","year":"1984","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.survophthal.2008.04.005_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.survophthal.2008.04.005_bib45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.survophthal.2008.04.005_bib46","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpeds.2004.01.049","article-title":"Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care","volume":"144","author":"Wilcox","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.survophthal.2008.04.005_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.survophthal.2008.04.005_bib48","first-page":"599","article-title":"[Morphological bases of the specific ocular changes in Fabry's disease]","volume":"154","author":"Witschel","year":"1969","journal-title":"Klin Monatsbl Augenheilkd"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625708000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625708000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:34:10Z","timestamp":1758540850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625708000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0039625708000507"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2008.04.005","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Features of Fabry Disease: Diagnosis of a Treatable Life-threatening Disorder","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2008.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}